n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, October 24th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

theMaven, Inc. (MVEN)

Stockhouse and InvestorsHub reported on theMaven, Inc. (MVEN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

theMaven, Inc. is an expert-driven, group media network. The Company’s advanced platform serves, by invitation-only, an alliance of professional, independent channel partners. theMaven’s executive team and operational board members include digital media pioneers Mr. James Heckman and Mr. Ross Levinsohn, and also technology innovators Mr. Bill Sornsin and Mr. Ben Joldersma. A digital media start-up, theMaven has its headquarters in Seattle, Washington. The Company lists on the OTC Markets Group’s OTCQB.

theMaven provides elite content leaders an end-to-end digital platform within a cooperative that shares resources and distribution and maximizes monetization. theMaven enables partners to focus on the important drivers of their businesses - creating, informing, sharing, discovering, leading, and interacting with the communities and constituencies they serve. theMaven enables partners to do so through providing broader distribution, greater community engagement, and efficient advertising and membership programs.

Recently, theMaven announced that it signed, and is in the process of integrating, greater than 60 channel partners (Mavens) into the Company’s coalition and that Q2 expenses tracked with internal forecasts as it builds toward a network rollout. The Company’s platform was unveiled in May 2017 and it plans a formal launch in this fourth quarter.

During Q2 of 2017, theMaven centered on three key strategic initiatives - developing its technology platform, business development to sign new Mavens to its network, and launching operations with certain Mavens.

KidsActivitiesBlog.com is now delivering its wealth of content through the new digital media network Maven. KidsActivitiesBlog.com is a leader in the world of family-focused advice, ideas, and information. It provides hundreds of educational, artistic, and also seasonal activity ideas for children to enjoy with parents, grandparents, and babysitters. The channel includes videos, articles, as well as live chats.

Last week, theMaven announced that Mr. Mike “Mish” Shedlock, whose MishTalk.com has received recognition by TIME magazine and others as one of the nation’s top financial blogs, is now amplifying his international economic analyses and commentary by way of the expert-driven digital media platform Maven.

MishTalk centers on interest rates, gold and precious metals, central bank policy, and more. Mr. Shedlock is an investment advisor for Sitka Pacific Capital Management near Seattle.

Mr. Shedlock said, “I decided to bring MishTalk to Maven because I like their veteran leadership team. All of them, from CEO James Heckman on, have proven themselves in impressive ways in digital media over many years. I believe they will better promote the Mish brand than I can operating independently. The community engagement tools and monetization possibilities alone will be transformative.”

theMaven, Inc. (MVEN), closed Tuesday's trading session at $1.29, down 3.01%, on 1,000 volume with 2 trades. The average volume for the last 60 days is 9,958 and the stock's 52-week low/high is $0.50/$2.00.

Grom Social Enterprises, Inc. (GRMM)

InvestorsHub, PinkSheets, and Stockhouse reported on Grom Social Enterprises, Inc. (GRMM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Grom Social Enterprises, Inc. owns five separate subsidiaries. This includes Grom Social, which is a safe social media platform for children between the ages of five and 16. Grom Social (established in 2012) has attracted children and parents with the promise of a safe and secure environment where their kids can be entertained and can interact with their peers while learning proper digital citizenship. Grom Social Enterprises has its corporate office in Boca Raton, Florida.

With Grom Social, kids can create a profile; make friends, chat, and also share content. Grom is a social community with a broad array of original content and engaging features. These include exclusive Grom TV videos, fun Grom games, interesting photos, and thought provoking Fan Pages. These range in topics from good digital citizenship and internet safety, to entertainment, sports, creative DIY (Do-It-Yourself) projects and more.

Inappropriate content or behavior (photos, language, bullying, and more) on Grom Social is identified by digital filters as well as the Company’s cast of Grom Helpers. Grom Helpers are real people. They monitor the website 24 hours a day, 7 days a week, 365 days a year.

Grom Social has its Parent Portal. This is a tool available to parents and guardians that permits them to monitor and control all of their child’s activity on Grom Social. Parents can set privacy settings; examine chat histories; and also review and control who their child is friends with.

In addition, Grom Social Enterprises owns and operates Top Draw Animation, Inc. This is an award-winning animation enterprise that produces animated content for Grom Social and other high-profile media properties including Tom and Jerry, My Little Pony, and Disney Animation's Penn Zero: Part-Time Hero.

Also, Grom Educational Services provides web filtering services for up to an additional two million children across 3,700 schools and libraries. Moreover, Grom Nutritional Services is in the process of creating a line of healthy nutritional supplements for children.

Last week, Grom Social Enterprises announced that its Grom Social, Inc. subsidiary exceeded 6 million users. In addition to its 6 million children users, Grom Social has a nearly equivalent number of parent and guardian users. Grom has a worldwide user base, with users in more than 200 countries. It is presently adding 300,000 new users signing up monthly.

Grom has one of the longest session duration times in the social media industry. Users spend an average of 52 minutes on the site each visit.

Grom Social Enterprises, Inc. (GRMM), closed Tuesday's trading session at $0.92, even for the day, on 14,000 volume with 9 trades. The average volume for the last 60 days is 3,540 and the stock's 52-week low/high is $0.7707/$3.05.

Lixte Biotechnology Holdings, Inc. (LIXT)

Real Pennies reported earlier on Lixte Biotechnology Holdings, Inc. (LIXT) and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Lixte Biotechnology Holdings, Inc. is a drug discovery company listed on the OTC Markets Group’s OTCQB. The clinical-stage Company employs biomarker technology to identify enzyme targets associated with serious common diseases and subsequently designs novel compounds to attack those targets. Lixte’s product pipeline covers two major categories of compounds at different stages of pre-clinical and clinical development, which the Company believes have extensive therapeutic potential for cancer and other debilitating and life-threatening diseases. Lixte Biotechnology’s corporate office is in East Setauket, New York.

The Company’s dedication is to discovering drugs for more effective treatments for cancer. It has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models.

Lixte’s present drug portfolio includes inhibitors of protein phosphatases that are vital to cell division and DNA damage repair, and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation.

The Company’s innovative phosphatase inhibitor is LB-100, its lead compound. LB-100 is in a Phase I clinical trial at two NCI designated Comprehensive Cancer Centers and three U.S. Oncology Research locations.

Lixte Biotechnology granted an exclusive license of its LB-100 for the treatment of hepatocellular carcinoma (HCC) in Asia to Taipei Medical University (TMU). LB-100 is not presently approved for treatment of HCC. Under the license, Taipei Medical University will determine the effectiveness of LB-100 against HCC in clinical trials conducted in compliance with Taiwanese and American regulatory requirements. TMU will pay milestone and royalty payments to Lixte Biotechnology.

Lixte Biotechnology presented a late-breaking abstract earlier in 2017 entitled "Protein phosphatase 2A inhibition with a novel small molecule inhibitor, LB-100, achieves durable immune-mediated antitumor activity when combined with PD-1 blockade in a preclinical model" as a poster (abstract number LB-193) at the American Association for Cancer Research (AACR) Annual Meeting 2017 in Washington, DC on April 4th. The research was done in collaboration with scientists at the National Institute of Neurological Disorders and Stroke (NINDS), NIH.

Lixte Biotechnology’s cancer drug development strategy has led to the discovery of novel compounds. These have the potential to be therapeutically useful against a number of other important but seemingly dissimilar diseases. The phosphatase inhibitors are in pre-clinical development for decreasing the extent of tissue damage following stroke, heart attack, and septic shock. The deacetylase inhibitors are in pre-clinical development for the prevention and treatment of neurodegenerative diseases, traumatic brain injury, and topically for fungal dermatitis.

Lixte Biotechnology Holdings, Inc. (LIXT), closed Tuesday's trading session at $0.15, even for the day. The average volume for the last 60 days is 17,291 and the stock's 52-week low/high is $0.085/$0.42.

Nanophase Technologies Corp. (NANX)

Schaeffer’s, CoolPennyStocks, BullRally, Stock Rich, HotOTC, Penny Invest, StockEgg, Wall Street Resources, SmarTrend Newsletters, Investment Contrarians, RedChip, Profit Confidential, and Stealth Stocks reported on Nanophase Technologies Corp. (NANX), and today we also report on the Company, here at the QualityStocks Daily Newsletter.

Nanophase Technologies Corp. is a technology leader in nanomaterials and advanced nanoengineered products. The OTCQB-listed Company provides nanoengineered solutions for many industrial product applications. Nanophase assists its customers in succeeding, with proprietary and patent protected technologies. These technologies allow them to create innovative products. Nanophase Technologies is headquartered in Romeoville, Illinois.

The Company creates products with original performance attributes from two ISO 9001:2008 and ISO 14001 facilities. Nanophase’s products include Aluminum Oxide, Antimony Tin Oxide, Bismuth Oxide, Cerium Oxide, Iron Oxide, and Zinc Oxide. Nano metal oxides provide UV protection across plastics, exterior coatings, and textile applications. Infrared absorbing particles create high clarity, energy saving films and interlayers.

Nanophase Technologies delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. The Company produces engineered nanomaterial products for use in an array of markets. These markets include Surface Finishing, Exterior Coatings, Personal Care, Plastics, Scratch Resistant Coatings, and Textiles.

Nanophase Technologies’ nano and submicron Aluminum Oxide imparts scratch resistance to coatings for wood, laminates, packaging, graphic arts, and electronics. Nano metal oxide technology improves the longevity and capacity of zinc anode-based batteries.

Regarding nanoparticle production technology, the traditional and most customary manufacturing methods utilized at the Company are plasma-based. The Physical Vapor Synthesis (PVS) and NanoArc® Synthesis (NAS) methods use transferred and non-transferred electric arcs to vaporize precursor materials.

These are then carefully condensed to produce nanoparticles with desired properties. These methods have been used to produce simple and complex, multi-component mixed metal oxides.

Concerning nanoparticle surface treatment, Nanophase Technologies uses patented and proprietary particle coating technology to tailor the surface of the nanoparticles by discreetly encapsulating individual particles. The process can be utilized to impart an extensive range of functionality to the particles that, in addition to helping to ensure success in the application, provides the Company’s customers with a significant deal of flexibility in formulation with the nanoparticles.

Nanophase Technologies practices these surface treatment and coating processes on metric ton quantities. The Company can provide the products in dry powder or pre-dispersed formats.
Nanophase Technologies will disseminate a financial news release for Q3 2017 on Wednesday, October 25, 2017, at 3:00 p.m. CDT, 4:00 p.m. EDT. The news release will be followed by the Q3 financial conference call on Thursday, October 26, 2017, at 10:00 a.m. CDT, 11:00 a.m. EDT.

Nanophase Technologies Corp. (NANX), closed Tuesday's trading session at $0.7399, up 4.21%, on 2,060 volume with 3 trades. The average volume for the last 60 days is 9,839 and the stock's 52-week low/high is $0.40/$0.78.

Aurvista Gold Corporation (ARVSF)

MarketWatch, OTC Markets, Stockhouse, and Barchart reported on Aurvista Gold Corporation (ARVSF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aurvista Gold Corporation is a gold exploration and Development Company centered on advancing one of the largest undeveloped gold projects in the Province of Quebec. Its district-scale Douay Gold Project is situated along the Casa Berardi Deformation Zone within the prolific Abitibi Greenstone Belt in northern Quebec. Aurvista Gold has its corporate office in Montreal, Quebec. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Douay Gold Project hosts an inferred gold resource, which remains open in a number of directions, with first-class infrastructure and many large scale operating mines within 150 kilometers. The Douay Gold Project’s high-grade lenses have never been mined. Aurvista Gold has aggressive property-wide exploration and drilling plans, with the goal of establishing high-quality ounces in one of the best mining jurisdictions globally.

The Douay Gold Project is covered by airborne magnetic and airborne EM surveys. These provide a strong foundation for interpretation of stratigraphic and structural trends, coupled with the potential for direct detection of gold and base metal mineralization associated with conductive and magnetic features.

Aurvista Gold has decided that further expenditure on airborne geophysical data is not warranted currently. However, detailed ground surveys centered on specific targets will be considered for target definition.

Regarding the Brownfields and Greenfields potential at the Douay Gold Project, Aurvista Gold controls a large 40-plus kilometer long segment along the Casa Berardi Deformation Zone (the CBDZ). This is one of a number of regionally productive structural "breaks" within the Abitibi Greenstone Belt. It is host to numerous gold and base metal deposits. A central, approximately 7 kilometer long portion of this segment on the CBDZ North Break hosts defined Inferred Mineral Resources (the Douay Resources) totalling 2.8 million ounces of gold (83.33 Mt @ 1.05 g/t Au, using a 0.5 g/t cut-off; Micon, 2017).

Aurvista Gold’s President and Chief Executive Officer, Mr. Matthew Hornor, stated last month, "We believe the potential for defining additional resources and making new high-grade gold discoveries are very favourable based on the existing resource, large property package and prospective geology. Our technical team has developed a strategy and program that will establish high-quality drill-targets beyond the known resource areas, and we will commence our diamond drilling campaign in the coming months once we've refined our resource extension and greenfields discovery targets."

This month, Aurvista Goldannounced the appointment of Mr. Jay Chmelauskas as its new Chairman of the Board of Directors. The Company’s former Chairman, Mr. Gerald McCarvill, continues to serve as an Aurvista Gold Board Member.

Mr. Chmelauskas has been a Corporate Development Consultant for the past year since the merger of Western Lithium and Lithium Americas. He served in several roles with Western Lithium USA Corporation including Director and President and Chief Executive Officer dating back to 2008.

Aurvista Gold Corporation (ARVSF), closed Tuesday's trading session at $0.209, up 1.06%, on 178,954 volume with 46 trades. The average volume for the last 60 days is 62,080 and the stock's 52-week low/high is $0.1032/$0.3411.

Rhino Resource Partners LP (RHNO)

Wall Street Mover, Marketbeat, TopPennyStockMovers, and PCG Advisory reported earlier on Rhino Resource Partners LP (RHNO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rhino Resource Partners LP is a diversified energy limited partnership listed on the OTC Market’s Group’s OTCQB. The Company centers on coal and energy related assets and activities. This includes energy infrastructure investments. Rhino is a diversified energy MLP (Master Limited Partnership) that produces coal in many basins in the U.S. Rhino Resource Partners is based Lexington, Kentucky.

The Company produces metallurgical and steam coal in an assortment of basins across the United States. In addition, Rhino leases coal by way of its Elk Horn subsidiary. The Company’s business strategy is to acquire coal reserves and properties with relatively long lives and that could undergo development with low risk at a reasonable cost.

Rhino Resource Partners produces steam coal used to generate electricity and metallurgical coal used in the steel-making process. In addition, Rhino manages and leases coal properties and collects royalties from such management and leasing activities. Additionally, the Company has oil and gas investments in the Cana Woodford area that provides added cash flows to its business.

Since April 2003, Rhino Resource Partners has completed several coal asset acquisitions, with a total purchase price of roughly $357.5 million. Through these acquisitions and other coal lease transactions, it has substantially increased its proven and probable coal reserves and non-reserve coal deposits. Also, Rhino has successfully grown its coal production via internal development projects.

Rhino Resource Partners announced in December 2016, that it entered into an option agreement with Royal Energy Resources, Inc. (ROYE), Rhino Resource Partners Holdings, LLC (Rhino Holdings), an entity wholly-owned by certain investment partnerships managed by Yorktown Partners LLC, and Rhino GP LLC, the general partner of Rhino. Rhino received an option (Call Option) from Rhino Holdings to acquire substantially all of the outstanding common stock of Armstrong Energy, Inc. presently owned by investment partnerships managed by Yorktown.

The Option Agreement specifies that Rhino can exercise the Call Option no earlier than January 1, 2018, and no later than December 31, 2019. In exchange for Rhino Holdings granting Rhino the Call Option to purchase Armstrong Energy, the Partnership issued 5.0 million new common units (Call Option Premium Units) to Rhino Holdings upon the execution of the Option Agreement.

This past August, Rhino Resource Partners announced its financial and operating results for the quarter ended June 30, 2017. The Partnership reported Net Income of $0.3 million and Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) of $6.9 million, versus a Net Loss of $121.9 million and Adjusted EBITDA of $4.5 million in Q2 of 2016.

Total Revenues for the quarter were $56.5 million, with coal sales producing $54.7 million of the total, versus Total Revenues of $41.6 million and coal revenues of $39.1 million in Q2 of 2016.

Rhino Resource Partners LP (RHNO), closed Tuesday's trading session at $2.21, even for the day, on 1,089 volume with 10 trades. The average volume for the last 60 days is 2,264 and the stock's 52-week low/high is $1.10/$5.99.

CanAlaska Uranium Ltd. (CVVUF)

FeedBlitz and OTC Markets Group reported earlier on CanAlaska Uranium Ltd. (CVVUF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

A project generator, CanAlaska Uranium Ltd. is an exploration stage enterprise listed on the OTC Markets Group’s OTCQB. The Company concentrates on two key projects in the Athabasca Basin in the Province of Saskatchewan. Founded in 1985, the Company formerly went by the name CanAlaska Ventures Ltd. It changed its corporate name to CanAlaska Uranium Ltd. in October 2006. The Company is headquartered in Vancouver, British Columbia.

CanAlaska Uranium says it’s positioned for discovery success in the world's richest uranium district. CanAlaska Uranium holds interests in about 500,000 hectares (1.2 million acres), one of the largest land positions in Canada's Athabasca Basin region. Its strategic holdings have attracted major global mining companies. At present, CanAlaska is working with Cameco and Denison at two of CanAlaska’s properties in the Eastern Athabasca Basin.

CanAlaska Uranium’s projects include Cree East, West McArthur, NW Manitoba, as well as base metals and gold projects and other uranium projects and its diamond projects. The Cree East project is a high-priority property situated in the south-eastern portion of the Athabasca Basin. The project consists of 16 contiguous mineral claims totaling 55,935 ha.

The West McArthur project is contiguous to the world’s richest uranium mine -Cameco's McArthur River. The objective at West McArthur is a large unconformity uranium deposit. Additionally, $20 million of work successfully identified seven target areas.

The Company’s NW Manitoba project lies in northwest Manitoba just east of the border of northeast Saskatchewan. It is 70 kilometers north of Reindeer Lake and covers 143,603 hectares.

In May of this year, CanAlaska Uranium announced results from the four reconnaissance drill holes at the Nisku target positioned 7 kilometers east of the Company’s North Ruttan copper-zinc property in the Leaf Rapids region of northern Manitoba. Drilling intersected massive iron sulphides between surface and 150 meters depth, with elevated copper mineralization in holes NSK001, NSK002, and NSK003.

Drill hole NSK004, situated to the east, intersected volcanics with minor sulphides. The drilling tested a coincident VTEM magnetic and electromagnetic target that has the characteristics of a large volcanogenic massive sulphide (VMS) deposit. The target is 10 kilometers east of the past producing Ruttan copper-zinc massive sulphide mine. The Ruttan mine was one of the largest VMS deposits in Canada.

Last month, CanAlaska Uranium reported interim results from drill hole WMA042-2, a wedge from mineralized drill-hole WMA042 (1.4 percent eU3O8 over 5.1 meters), on the West McArthur uranium project. The continuing drill program is being conducted by Cameco Corporation.

In addition, in September, CanAlaska Uranium announced that it acquired two Mineral Exploration Licences encompassing more than 16,000 hectares (63 sq miles) in an area highly prospective for sulphide nickel situated 25 kilometers northwest of the town of Thompson and Vale's nickel smelter and mining operations. The land package covers broad areas of favorable nickel geology identified in historical work by Inco and Falconbridge.

The Thompson Nickel Belt is a 350 kilometer long nickel dominant mineral belt in northern Manitoba. The Belt hosts several massive to disseminated nickel sulphide deposits.

CanAlaska Uranium Ltd. (CVVUF), closed Tuesday's trading session at $0.2404, down 8.97%, on 31,200 volume with 12 trades. The average volume for the last 60 days is 10,168 and the stock's 52-week low/high is $0.2362/$0.593.

graphic

The QualityStocks
Company Corner

graphic
graphic

Grey Cloak Tech, Inc. (GRCK)

The QualityStocks Daily Newsletter would like to spotlight Grey Cloak Tech, Inc. (GRCK). Today, Grey Cloak Tech, Inc. closed trading at $0.0178, up 27.14%, on 35,394,880 volume with 825 trades. The stock’s average daily volume over the past 60 days is 3,638,101 and its 52-week low/high is $0.0091/$0.35.

Grey Cloak Tech, Inc. (GRCK) announced today that it has acquired 100% in an all-stock transaction Eqova Life Sciences, a medically-focused CBD company. According to The Hemp Business Journal, CBD products marketplace are projected to grow by 700% by 2020 with annual sales reaching $2.1 billion.

Grey Cloak Tech, Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, aims to expand into the rapidly growing cannabinoid (CBD) market through the pending acquisition of Eqova Life Sciences, which focuses on providing a full spectrum line of clinical-grade hemp oil (CBD) products to the medical practitioner market. Eqova Life Sciences, based in Denver, Colorado, develops its own high quality, branded product line of hemp oil health products, with the offer of producing private labels to qualified partners.

Eqova Life Sciences recently exhibited the company's CBD products at the Integrative Medicine Summit in Denver, Colorado, which was attended by over 200 medical professionals. As part of the exhibition, Eqova Life Sciences also debuted its new CannaBio Salve, an innovative topical salve infused with several aromatic natural oils. The company's formulations combine the scientifically-validated, powerful benefits of cannabinoids in standardized products which are then distributed to patients under the care of qualified health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing the security of a clinical-grade product made in cGMP Compliant Labs located in the United States.

According to The Hemp Business Journal, the CBD products marketplace is projected to grow 700 percent by 2020 with annual sales reaching $2.1 billion. The purchase of Eqova Life Sciences would be a natural fit for the company, which has been looking for a way to build shareholder value by adding acquisitions from the rapidly growing CBD sector. Grey Cloak Tech believes medical practitioners seeking high-quality CBD products represent a vastly underserved market. To date, no other hemp oil company has exclusively focused on providing clinical-grade, full-spectrum hemp oil products to this important segment of the medical community.

Grey Cloak Tech also develops advanced software to overcome costly digital threats, most commonly known as online fraud. Grey Cloak Tech leads the industry with continuous development of the most comprehensive and effective weapons against online security threats. The company's proprietary digital advertising fraud detection software, Fraudlytic, provides a cloud-based, secure platform that monitors Internet traffic in real time, blocking malicious and false clicks, while allowing real consumers to view offers and make purchases. Disclaimer

Grey Cloak Tech, Inc. Blog

Grey Cloak Tech, Inc. News:

Grey Cloak Tech Completes Acquisition of Eqova Life Sciences

Grey Cloak Tech Commences Trading on the OTCQB Venture Market

Grey Cloak's Acquisition Target Eqova Exhibits at Denver's Integrative Medicine Summit

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.3461, up 16.65%, on 1,933,710 volume with 869 trades. The stock’s average daily volume over the past 60 days is 471,454, and its 52-week low/high is $0.09/$0.72.

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today results from a study co-sponsored by InMed (Dr. Sazzad Hossain, Chief Scientific Officer) and the University of British Columbia (laboratories of Profs. Ujendra Kumar and Vikramaditya Yadav).

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid

InMed Updates Pain Program

InMed Appoints Dr. Mauro Maccarrone to its Scientific Advisory Board

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.06, up 3.45%, on 1,233,981 volume with 151 trades. The stock’s average daily volume over the past 60 days is 3,684,865, and its 52-week low/high is $0.002/$0.0995.

PotNetwork Holding, Inc. (POTN) is pleased to announce that its wholly owned subsidiary, Diamond CBD, Inc., has enhanced its product line with a delicious selection of premium honey products. Among these new products, the company will have delicious honey packed straws infused with 10mg of pure natural organic CBD. With the potentially beneficial attributes of both cannabis and honey known for centuries, Diamond CBD’s highly anticipated Infused Honey Sticks may offer a whole new tasty way to enhance wellness and boost the immune system. Comprised of 100% full spectrum CBD and all natural honey, these delicious straws are expected to be a welcomed item providing enthusiasts with a practical and beneficial delivery method of nature’s gifts as revealed in studies in the Asian Pacific Journal of Tropical Biomedicine and available upon the inevitable opening of flu season.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

PotNetwork Holding, Inc. Subsidiary, Diamond CBD, Brings to Market Tasty Honey Selections Including Featured Premium Organic CBD-Infused Honey Sticks

NetworkNewsWire Announces Publication Discussing CBD Alternatives to Traditional Medicine

PotNetwork Holding, Inc. Projects Third Quarter Revenues Will Top First Six Months Results, Based on Record Sales Volume for July and August

EVIO, Inc. (EVIO)

The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO). Today, EVIO, Inc. closed trading at $0.5201, up 0.02%, on 46,290 volume with 65 trades. The stock’s average daily volume over the past 60 days is 12,620, and its 52-week low/high is $0.49/$5.45.

EVIO, Inc. (EVIO), the nation's leading provider of analytical laboratory cannabis testing, research and advisory services, has announced the opening of its fifth testing location in eastern Oregon. "We are excited to announce our new location in La Grande, OR," stated William Waldrop, CEO of EVIO, "Oregon recently passed OAR 603-048 which requires all industrial hemp and hemp derived manufactured products to be tested by an accredited testing lab prior to being made available for sale. Our new location, is the only lab in eastern Oregon and is strategically located near a significant number of Oregon's 233 licensed hemp growers and 173 licensed manufacturers and distributors."

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation's leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation's cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation's leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today's fastest growing industry. Disclaimer

EVIO, Inc. Company Blog

EVIO, Inc. News:

EVIO Labs Expands to Fifth Oregon Location

EVIO Labs Sees Demand for Testing Services Double

EVIO, Inc. (EVIO) is “One to Watch”

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.05954, off by 0.62%, on 2,822,534 volume with 244 trades. The stock’s average daily volume over the past 60 days is 17,418,012, and its 52-week low/high is $0.0075/$0.415.

Singlepoint, Inc. (SING) has entered into a Letter of Intent with AppSwarm (SWRM) to conduct a joint roll-out of mobile applications specifically geared to the cannabis industry. The applications will be branded and marketed under SinglePoint’s SingleSeed subsidiary (www.SingleSeed.com), while AppSwarm (www.app-swarm.com/) will provide the necessary technical support and app development. 

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint and AppSwarm Sign LOI to Launch Cannabis-Focused Applications

SinglePoint Completes Acquisition of Profitable Denver Colorado-Based Company

CannabisNewsWire Announces Publication on Public Companies Offering Secondary Services to the Cannabis Industry

AppSwarm, Inc. (SWRM)

The QualityStocks Daily Newsletter would like to spotlight AppSwarm, Inc. (SWRM). Today, AppSwarm, Inc. closed trading at $0.012, off by 6.25%, on 574,513 volume with 20 trades. The stock’s average daily volume over the past 60 days is 143,979 and its 52-week low/high is $0.002/$0.04.

Singlepoint, Inc. (SING) has entered into a Letter of Intent with AppSwarm (SWRM) to conduct a joint roll-out of mobile applications specifically geared to the cannabis industry. The applications will be branded and marketed under SinglePoint’s SingleSeed subsidiary (www.SingleSeed.com), while AppSwarm (www.app-swarm.com/) will provide the necessary technical support and app development. 

AppSwarm, Inc. (SWRM) is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. Focusing on the ever-growing mobile applications market, the company provides all the resources needed for engagement, retention, virality and monetization.

The global games market generated approximately $100 billion in revenues in 2016, but large global game companies have made it extremely difficult for smaller developers to achieve success in the marketplace. As a result, many great ideas aren't monetized. AppSwarm solves this problem by providing the funding and critical business expertise needed to successfully launch and market new applications.

Business applications is another area of focus for the company. Targeting small to medium sized businesses, AppSwarm will be developing and acquiring mobile application tools and platforms that increase productivity and security via data encryption, cloud storage, content management and delivery, digital payments, automation, and customer loyalty marketing solutions. Recent acquisitions made so far represent only a small example of future planned initiatives to develop and market tools for the business community.

Regardless of the target market, AppSwarm can help developers accelerate the success of their app through funding, technology and marketing expertise, as well as a unique eco system that accelerates user acquisition. The company is able to assist at any state of development with completion of concept, market analysis, business and financial management, direct sales and marketing, social game development to ensure correct product application and expedient deployment with cost efficiency.

Ron Brewer, CEO of the company, has accumulated extensive leadership in the technology sector and brings valuable knowledge gained as a Director of Southbridge Advisory Group for nearly 20 years. Ron's C-level experience includes merger & acquisition and post-acquisition turnaround in both the private and small-cap public sector. John Rabbit, director of finance, is a seasoned business veteran that has worked with Fortune 500 firms and served in CEO, COO and CFO positions for firms ranking from $5 million to $300 million in annual revenues. John was directly involved in numerous acquisitions and served in executive capacities for several multinational subsidiaries.

With a well-suited management team, multiple synergistic revenue streams, and diversified growth strategy, AppSwarm is well positioned in a steadily growing industry with countless opportunities for capitalization. Disclaimer

AppSwarm, Inc. Blog

AppSwarm, Inc. News:

AppSwarm and SinglePoint Sign LOI to Launch Cannabis-Focused Applications

AppSwarm, Inc. Announces Joint Venture with Last-Mile Delivery Firm Estorerunner

AppSwarm, Inc. is Developing Last-Mile Delivery Application Management Platform

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0177, off by 7.11%, on 7,594,959 volume with 155 trades. The stock’s average daily volume over the past 60 days is 3,018,336, and its 52-week low/high is $0.0077/$0.04.

Global Payout, Inc. (GOHE) is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC,” the “Company”) has established a strategic partnership with Pegasus Fintech, Inc., an innovative blockchain and token accelerator company delivering regulatory-compliant solutions in the financial services, technology, blockchain, and cryptocurrency market sectors.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Global Payout’s MoneyTrac Technology, Inc. Partners with Innovative Blockchain and Token Accelerator Pegasus Fintech, Inc. for Joint Development of Cryptocurrency-Based Token

Global Payout, Inc. is Finalizing Audit in Preparation for its Listing on the OTCQB Venture Marketplace.

NetworkNewsWire Announces Publication on Innovative Companies Serving Specific Needs in the Cannabis Industry

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

MarketBeat
(QRMLF) +400.00%

2.

PennyPickGains
(STGZ) +99.33%

3.

MegaPennyStocks
(IVST) +77.89%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251